Investor Information
Company Fact Sheet
Rubicon Research is a leading specialty pharmaceutical company with a focus on formulation development and drug delivery technologies. We leverage our proprietary technologies and deep scientific expertise to develop high-quality, value-added products for global markets.
| Corporate Identity | Rubicon Research Limited |
| Year of Incorporation | 1999 |
| Core Capabilities | Specialty Generics, Drug Delivery Technologies, CDMO Services, Formulation R&D |
| Global Presence | R&D Center in Mumbai (India); State-of-the-art Manufacturing Facilities in Ambernath (India) and USA |
| Registered Office | MedOne House, Plot No. B-75, Road No. 33, Wagle Estate, Thane (W) 400604, Maharashtra, India |
| BSE Script Code | 544578 |
| NSE Script Code | RUBICON |
| ISIN | INE506V01022 |
Quick Links:
Corporate HQ
Thane, India
R&D Centers
Thane, India
Concord, Canada
Manufacturing Plants
Ambernath, India
Satara, India
Business Development & Regulatory Office
New Jersey, USA
Consumer Healthcare
Thane, India
Learning Solutions
Thane, India
CIN: L73100MH1999PLC119744
Investor Relations: Investors@rubicon.co.in
Deepashree Tanksale – Company Secretary and Compliance Officer
Ketan Thakkar – General Manager - Finance
Copyright © 2026. Rubicon Research Limited (formerly known as Rubicon Research Private Limited). All rights reserved